873464-04-1

Basic information

• Product Name: Benzoic acid, 3-[(acetylthio)methyl]-
• CAS NO: 873464-04-1
• Molecular Formula: C10H10O3S
• Molecular Weight: 210.254
• Mol File: 873464-04-1.mol

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-[(acetylthio)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-[(acetylthio)methyl]-(873464-04-1)
• EPA Substance Registry System: Benzoic acid, 3-[(acetylthio)methyl]-(873464-04-1)

Safety Data

• Hazardous Substances Data: 873464-04-1(Hazardous Substances Data)

Upstream product

• 6515-58-8 3-bromomethylbenzoic acid 
• 10387-40-3 potassium thioacetate 
• 31719-77-4 3-chloromethylbenzoic acid 

Downstream Products

• 1354722-18-1 tert-butyl 3-(3-(4-chloro-2-(1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-ylcarbamoyl)phenylcarbamoyl)benzylthio)propanoate 
• 1354721-65-5 3-((3-((4-chloro-2-((1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-yl)carbamoyl)phenyl)carbamoyl)benzyl)thio)propanoic acid 
• 1354722-10-3 tert-butyl 3-((3-((2-((1-(3,4-dimethylphenyl)-1H-pyrazol-3-yl)carbamoyl)-4-(piperidin-1-yl)phenyl)carbamoyl)benzyl)thio)propanoate 
• 1354721-64-4 3-((3-((2-((1-(3,4-dimethylphenyl)-1H-pyrazol-3-yl)carbamoyl)-4-(piperidin-1-yl)phenyl)carbamoyl)benzyl)thio)propanoic acid 
• 1354722-05-6 tert-butyl 3-(3-(4-chloro-2-(1-(3,4-dimethylphenyl)-1H-pyrazol-3-yl-carbamoyl)phenylcarbamoyl)benzylthio)propanoate 
• 1354722-00-1 tert-butyl 3-((3-(chlorocarbonyl)benzyl)thio)propanoate 
• 1354721-63-3 3-((3-((4-chloro-2-((1-(3,4-dimethylphenyl)-1H-pyrazol-3-yl)carbamoyl)phenyl)carbamoyl)benzyl)thio)propanoic acid 
• 1354722-30-7 C₃₇H₄₀F₃N₅O₄S 
• 1354721-80-4 3-((3-((4-(piperidin-1-yl)-2-((1-(3-(trifluoromethyl)phenyl)-1H-imidazol-4-yl)carbamoyl)phenyl)carbamoyl)benzyl)thio)propanoic acid 
• 1354653-04-5 tert-butyl 3-(3-(4-(piperidin-1-yl)-2-(5-(3-(trifluoromethyl)phenyl)pyrimidin-2-ylcarbamoyl)phenylcarbamoyl)benzylthio)propanoate 
• 1354652-67-7 3-(3-(2-(5-(3,4-dimethylphenyl)pyrimidin-2-ylcarbamoyl)-4-(piperidin-1-yl)phenylcarbamoyl)benzylthio)propanoic acid 
• 1354653-03-4 tert-butyl 3-(3-(2-(5-(3,4-dimethylphenyl)pyrimidin-2-ylcarbamoyl)-4-(piperidin-1-yl)phenylcarbamoyl)benzylthio)propanoate 
• 1354652-66-6 3-(3-((4-(piperidin-1-yl)-2-((5-(3-(trifluoromethyl)phenyl)pyrazin-2-yl)carbamoyl)phenyl)carbamoyl)benzylthio)propanoic acid 
• 1354653-01-2 tert-butyl 3-(3-((4-(piperidin-1-yl)-2-((5-(3-(trifluoromethyl)phenyl)pyrazin-2-yl)carbamoyl)phenyl)carbamoyl)benzylthio)propanoate 

Relevant articles and documents

Compounds and methods for inhibiting phosphate transport

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein X, Y, A, R1 and R2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac

Fluorine-substituted dihydrobicyclomycins: Synthesis and biochemical and biological properties

Many studies show that selective introduction of fluorine within pharmacological agents leads to improved activities. In this study, we determine the effects of aryl fluorine substitution in 5a-(benzylsulfanyl)- dihydrobicyclomycin (3) on the in vitro inh